Andrew D. Napper
Bristol-Myers Squibb (United States) · 94 works · 3,033 citations · h-index 24
Top works
- Substrate-specific Activation of Sirtuins by Resveratrol
- A Stereospecific Cyclization Catalyzed by an Antibody
- Discovery of Indoles as Potent and Selective Inhibitors of the Deacetylase SIRT1
- Catalysis of a stereospecific bimolecular amide synthesis by an antibody.
- Purification and characterization of multiple forms of the pineapple-stem-derived cysteine proteinases ananain and comosain
- Potentiometric biosensor employing catalytic antibodies as the molecular recognition element
- Antibody-Catalyzed Hydrolysis of an Unsubstituted Amide
- Assay Guidance Manual
- Identification of Specific Inhibitors of Human RAD51 Recombinase Using High-Throughput Screening
- Mechanistic studies of a tyrosine-dependent catalytic antibody
- Identification of Novel Inhibitors of Dietary Lipid Absorption Using Zebrafish
- Mitoxantrone Targets Human Ubiquitin-Specific Peptidase 11 (USP11) and Is a Potent Inhibitor of Pancreatic Cancer Cell Survival
- Identification of triazinoindol-benzimidazolones as nanomolar inhibitors of the Mycobacterium tuberculosis enzyme TDP-6-deoxy-d-xylo-4-hexopyranosid-4-ulose 3,5-epimerase (RmlC)
- Discovery of Potent Small-Molecule Inhibitors of Multidrug-Resistant Plasmodium falciparum Using a Novel Miniaturized High-Throughput Luciferase-Based Assay
- Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms
- Assay Guidance Manual : Quantitative Biology and Pharmacology in Preclinical Drug Discovery
- Microplate filtration assay for nicotinamide release from NAD using a boronic acid resin
- Identification and characterization of 3-substituted pyrazolyl esters as alternate substrates for cathepsin B: The confounding effects of DTT and cysteine in biological assays
- Drug Discovery for Duchenne Muscular Dystrophy via Utrophin Promoter Activation Screening
- Kinetic Characterization and Molecular Docking of a Novel, Potent, and Selective Slow-Binding Inhibitor of Human Cathepsin L